Johnson & Johnson Co DRC (JNJm)

Buenos Aires


	Symbol		Exchange		Currency
	JNJm		Buenos Aires		ARS	Delayed
	DJNJ3m		Buenos Aires		ARS	Delayed
	DJNJ2m		Buenos Aires		ARS	Delayed
	JNJ		NYSE		USD	Real-time
	JNJ		CBOE Canada		CAD	Real-time
	JNJ		Mexico		MXN	Delayed
	1JNJ		Milan		EUR	Real-time
	JNJ		Frankfurt		EUR	Delayed
	JNJ		TradeGate		EUR	Delayed
	JNJ		Xetra		EUR	Delayed
	JNJB34		B3		BRL	Delayed
	JNJ		Vienna		EUR	Real-time
	JNJ		Ukraine		UAH	Delayed
	JNJ_KZ		KASE		USD	Delayed
	JNJ		Colombia		COP	Delayed
	JNJ		Lima		USD	Delayed

Currency in ARS

Disclaimer

12,875.00

-75.00(-0.58%)

Closed08/10

Fair Value

Day's Range

12,850.00

13,025.00

52 wk Range

7,898.29

14,750.00

JNJm Income Statement

Featured here, the Income Statement (earnings report) for Johnson & Johnson Co DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

28/12

2016

03/01

2017

01/01

2017

31/12

2018

30/12

2019

29/12

2021

03/01

2022

02/01

2023

01/01

2023

31/12

Total Revenues

82,059

82,584

78,740

79,990

85,159

Total Revenues Growth

+0.59%

+0.64%

-4.65%

+1.59%

+6.46%

Cost Of Revenues

27,556

28,427

23,402

24,596

26,244

Gross Profit

54,503

54,157

55,338

55,394

58,915

Gross Profit Growth

+0.02%

-0.63%

+2.18%

+0.1%

+6.36%

Gross Profit Margin %

66.42%

65.58%

70.28%

69.25%

69.18%

Other Operating Expenses, Total

33,240

33,890

33,783

33,213

35,251

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.23%	+1.96%	-0.32%	-1.69%	+6.14%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	11,355	12,159	14,277	14,135	15,085
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	21,885	21,731	19,506	19,078	20,166
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

21,263

20,267

21,555

22,181

23,664

Operating Income Growth

+0.42%

-4.68%

+6.36%

+2.9%

+6.69%

EBIT Margin %

25.91%

24.54%

27.37%

27.73%

27.79%

Net Interest Expenses

39

-90

-130

214

489

Net Interest Expenses Growth

+109.9%

-330.77%

-44.44%

+264.62%

+128.5%

Interest Expense, Total

-318

-201

-183

-276

-772

Interest And Investment Income

357

111

53

490

1,261

Other Non Operating Expenses, Total

-4,176

-3,131

-766

1,458

1,298

EBT, Excl. Unusual Items

17,126

17,046

20,659

23,853

25,451

Gain (Loss) On Sale Of Assets

2,154

111

617

380

117

Other Unusual Items, Total

-1,986

-414

-1,889

-3,599

-8,908

EBT, Incl. Unusual Items

17,328

16,497

19,178

19,359

15,062

EBT, Incl. Unusual Items Growth

-3.73%

-4.8%

+16.25%

+0.94%

-22.2%

EBT, Incl. Unusual Items Margin

21.12%

19.98%

24.36%

24.2%

17.69%

Income Tax Expense

2,209

1,783

1,377

2,989

1,736

Net Income to Company

15,119

14,714

20,878

17,941

35,153

Minority Interest

-

-

-

-

-

Net Income

15,119

14,714

20,878

17,941

35,153

Net Income Growth

-1.16%

-2.68%

+41.89%

-14.07%

+95.94%

Net Income Margin %

18.42%

17.82%

26.52%

22.43%

41.28%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

15,119

14,714

17,801

16,370

13,326

Basic EPS - Continuing Operations

5.72

5.59

6.76

6.24

5.26

Basic EPS - Continuing Operations Growth

+0.2%

-2.22%

+21.01%

-7.8%

-15.65%

Diluted EPS - Continuing Operations

5.63

5.51

6.66

6.14

5.2

Diluted EPS - Continuing Operations Growth

+0.36%

-2.13%

+20.87%

-7.81%

-15.31%

Basic Weighted Average Shares Outstanding

2,645.1

2,632.8

2,632.1

2,625.2

2,533.5

Diluted Weighted Average Shares Outstanding

2,684.3

2,670.7

2,674

2,663.9

2,560.4

Dividend Per Share

3.75

3.98

4.19

4.45

4.7

Dividend Per Share Growth

+5.93%

+6.13%

+5.28%

+6.21%

+5.62%

EBITDA

28,272

27,498

28,206

28,510

30,767

EBITDA Growth

+0.6%

-2.74%

+2.57%

+1.08%

+7.92%

EBITDA Margin %